Please select a Capability in order to start your service request.
New BD Survey Conducted by HIMSS Analytics® Reveals Heightened Need for Seamless Integration of Disparate Technologies during Medication Transit. New BD Survey Conducted by HIMSS Analytics® Reveals Heightened Need for Seamless Integration of Disparate Technologies during Medication Transit.Mar 5, 2018
LAS VEGAS, Mar. 5, 2018 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its comprehensive approach to integrated, enterprise medication management to help close the communication gaps across the medication management process through increased interoperability, enhanced cybersecurity and expanded partnerships at the 2018 HIMSS Annual Conference being held in Las Vegas from March 5-9. Among the company's latest enhancements designed to provide seamless connectivity across BD's leading technologies and with the hospital's EMR provider, is the BD HealthSightTM platform, which offers a unique combination of connective technologies, analytics and expert services.
A new BD survey conducted by HIMSS Analytics®, 2017 Medication Management and Safety Survey, found more than 75 percent of physicians, nurses and pharmacists surveyed described the medication management process as "flawed," "fragmented," "disjointed" and "primitive." Additional results revealed:
"BD is partnering with IT industry leaders and collaborating with customers to help address these evolving medication management challenges," said Ranjeet Banerjee, worldwide president of Medication Management Solutions for BD. "By leveraging these partnerships, we will improve interoperability across the medication management process, enhance cybersecurity and develop advanced analytics to drive sustained customer outcomes."
The BD HealthSight platform for enterprise medication management, supports health systems as they address these challenges by helping to create a seamless ecosystem between BD PyxisTM and BD AlarisTM portfolios from pharmacy to bedside - with the goal of improving efficiency, reducing waste and enabling healthcare workers to spend more time on patient care.
At the 2018 HIMSS Annual Conference, BD will also highlight key enhancements in the areas of industry and clinical partnerships, enhanced interoperability and cybersecurity, to help address the evolving challenges hospitals and health systems face throughout the entire medication management process.
"Cloud and AI technologies are helping health organizations around the world streamline operations and deliver better outcomes for patients," said Neil Jordan, general manager, Worldwide Health at Microsoft. "Microsoft Azure and AI technologies, working together with innovative BD solutions, will help optimize the medication management process for healthcare providers."
BD's commitment to optimizing health IT to improve the entire medication management process will be presented through a range of onsite activities at HIMSS. For a complete list of speakers, symposia, sessions, white papers and other information BD will present at HIMSS, please visit BD.com/HIMSS18
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.